BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sucquart IE, Nagarkar R, Edwards MC, Rodriguez Paris V, Aflatounian A, Bertoldo MJ, Campbell RE, Gilchrist RB, Begg DP, Handelsman DJ, Padmanabhan V, Anderson RA, Walters KA. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model. Endocrinology 2021;162:bqab020. [PMID: 33522579 DOI: 10.1210/endocr/bqab020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Garg A, Patel B, Abbara A, Dhillo WS. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2022. [PMID: 35262967 DOI: 10.1111/cen.14704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Al-Hussaniy HA, Alburghaif AH, Naji MA. Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. J Med Life 2021;14:600-5. [PMID: 35027962 DOI: 10.25122/jml-2021-0153] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Abbara A, Dhillo WS. Targeting Elevated GnRH Pulsatility to Treat Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2021;106:e4275-7. [PMID: 34117885 DOI: 10.1210/clinem/dgab422] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Skorupskaite K, Anderson RA. Hypothalamic neurokinin signalling and its application in reproductive medicine. Pharmacol Ther 2021;:107960. [PMID: 34273412 DOI: 10.1016/j.pharmthera.2021.107960] [Cited by in F6Publishing: 1] [Reference Citation Analysis]